Pharosyn
United Kingdom · Enterprise software
AI-powered commercial intelligence for pharmaceutical teams, turning clinical, regulatory and market signals into traceable reports and decision support.
Intelligence built for pharma decisions
Pharosyn builds AI systems for pharmaceutical commercial teams, including competitive intelligence, portfolio strategy, market research, forecasting and business-development evaluation. Its current offering monitors clinical and regulatory developments, deals, hiring, epidemiology and social media, then filters activity against a company's asset strategy and produces reports and alerts that users can trace to source data.
From monitoring to working reports
The workflow combines software with Pharosyn's pharmaceutical and engineering specialists. For congress coverage, teams can prioritize titles and abstracts in advance, receive live-session coverage, then work with editable summary decks and ask follow-up questions in the platform. Pharosyn reports that a top-ten biopharma customer uses the system and that its monitoring deliverables can arrive in minutes rather than hours. Its wider decision-support infrastructure is positioned for customization inside a customer's environment; market-research and forecasting capabilities are described as extensions of that core system.
- Headquarters
- London, United Kingdom
- Product
- AI-powered commercial and competitive intelligence
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | $3M | Entrepreneurs First — ParticipantGeneral Advance — ParticipantMoonfire — ParticipantTranspose Platform — Participant |